SCHEMBL1389666

SCHEMBL1389666

Cc1ccccc1C(C/C(=N/O)c1ccncc1)c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 6/20 0.49
MAPT P10636 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
USP2 O75604 2/20 0.40
HTT P42858 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389667 1.00 GPBAR1 (0.49) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1389663 1.00 GPBAR1 (0.49) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1389527 0.90 GPBAR1 (0.63) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1389522 0.90 GPBAR1 (0.63) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1389528 0.90 GPBAR1 (0.63) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1389525 0.90 GPBAR1 (0.63) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL15949129 0.89 MAPT (0.45) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL369835 0.86 GPBAR1 (0.51) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL369834 0.86 GPBAR1 (0.51) GPBAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL10240898 0.86 GPBAR1 (0.51) GPBAR1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885MAPT 4149/4885SMN1; SMN2 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.